We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




"Smart” Wound Dressings Could Identify and Destroy Infection-Causing Bacteria

By HospiMedica International staff writers
Posted on 19 May 2010
A new study describes an innovative wound dressing system that releases an encapsulated antimicrobial agent only in the presence of pathogenic bacteria, allowing the body's normal microflora to continue providing a natural defense against infection. More...


Researchers at the University of Bath (United Kingdom) developed the prototype wound dressing, which is made of a nonwoven polypropylene fabric to which small vesicles containing an antibacterial agent are attached. When the pathogenic bacteria lyses the membranes of the vesicles attached to the smart fabric, they rupture, releasing the antibacterial agent and thus destroying the bacteria. By turning the virulence factors--toxins or enzymes that damage vesicle membranes--back onto the pathogens, the vesicle system can be thought of as a "Trojan horse,” inciting pathogenic bacteria to act as agents of their own destruction.

In their experiments, samples of a viable bacterial population of two species (Staphylococcus aureus and Pseudomonas aeruginosa) were tested every 20 minutes for four hours following exposure to the fabric. The researchers observed significant decreases in the concentrations of both species, and eventually nearly complete inhibition. The researchers also found that concentrations of P. aeruginosa declined at a faster rate than S. aureus, due to greater sensitivity of P. aeruginosa to the encapsulated antimicrobial agent.

The researchers also observed that in uninfected samples that contained only nonpathogenic Escherichia coli, concentrations of the E. coli were only slightly reduced, which likely resulted from minor leakage of the vesicles. By ensuring that the antibacterial agent is released only in the presence of pathogenic bacteria, the strategy minimizes evolutionary pressure for the selection of antibiotic-resistant bacteria, prolonging the effectiveness of the antibacterial agent. The study was published in the May 12, 2010, issue of the Journal of the American Chemical Society.

"The potential significance of this work is that we have a proof-of-principle of a ‘smart' system which is able to discriminate between pathogenic and nonpathogenic bacteria,” said study coauthor Toby Jenkins, Ph.D., of the department of biophysical chemistry. "The advantage of this in a wound dressing is that it will only release an antimicrobial if the wound becomes infected with dangerous bacteria, but won't respond to harmless commensal bacteria which may be present. This reduces the evolutionary selection pressure on bacteria of all types to evolve resistance and should slow the emergence of new antibiotic resistant species of bacteria such as MRSA.”

Related Links:
University of Bath



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Mammo DR Retrofit Solution
DR Retrofit Mammography
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.